论文部分内容阅读
目的:探讨复方米非司酮对皮下埋植避孕术后阴道异常出血的治疗效果。方法:62例皮下埋植避孕术异常出血的妇女随机分为观察组(每月服用复方米非司酮1片,共服6片)和对照组(服用安慰剂),每组31例。结果:观察组服用药期间出血天数较对照组减少(P<0.05),长期不规则出血比例也低于对照组(P<0.05),但滴血天数和停药后出血/滴血天数组间无明显差异(P>0.05)。结论:皮下埋植避孕术阴道异常出血应用复方米非司酮能够缩短出血天数,减少长期不规则出血、滴血天数,但出血模式没有变化。
Objective: To investigate the curative effect of compound mifepristone on abnormal vaginal bleeding after subdermal implantation of contraception. Methods: Sixty-two women undergoing subcutaneous implantation of contraceptive abnormalities were randomly divided into observation group (taking 1 tablet of mifepristone monthly for a total of 6 tablets) and control group (taking placebo), with 31 cases in each group. Results: The number of bleeding days in the observation group was lower than that in the control group (P <0.05), and the proportion of long-term irregular bleeding was also lower than that in the control group (P <0.05). However, the number of days of bleeding and the number of bleeding / No significant difference (P> 0.05). Conclusion: Subcutaneous implantation of vaginal bleeding in contraceptive vaginal application of mifepristone can shorten the number of bleeding days, reduce long-term irregular bleeding, bleeding days, but the bleeding pattern has not changed.